TCF POST Desk
New York: Covation Biomaterials, the innovator behind Sorona® elasterell-p, is showcasing its latest advancement, Xatryx® bioPTMEG, at the Functional Fabric Fair in New York.
As a next-generation bio-based performance materials company, Covation Bio is demonstrating how Xatryx®—a second-generation bio-based raw material. It enables functional textile performance while advancing the defossilization of the materials supply chain. This initiative is exemplified by their partnership with Huafon on bio-elastane innovation.
“Together, Xatryx® and Sorona® elasterell-p fiber demonstrate how we are reducing friction and increasing performance for our value chain partners while helping them decrease their environmental impact,” says Covation Bio CEO Steven Ackerman.
Xatryx® bioPTMEG is a second-generation, bio-based polyether glycol derived from corncobs, an abundant and renewable non-food agricultural by-product. It delivers functional performance paired with substantial sustainability benefits and serves as a drop-in replacement for traditional petroleum-based polytetramethylene ether glycol (PTMEG).
Covation Bio emphasizes that downstream customers can transition to Xatryx® without requiring changes to existing processes or production lines for performance apparel applications that traditionally utilize spandex, polyurethanes, and thermoplastic elastomers. Commercial production is expected to begin in the second half of 2026.
In parallel, Sorona® elasterell-p fiber is the first U.S.-produced bicomponent stretch fiber made with 37 percent plant-based Sorona® polymer. The fiber provides durable stretch and shape retention without the use of elastane.
It is currently available across the U.S. and Latin America, supported by local stock and dedicated customer service through regional distribution partner Mercados Internacionales (MI).
Sorona® elasterell-p is ideal for activewear, athleisure, workwear, uniforms, and other apparel applications requiring long-lasting comfort and durable stretch performance.
Founded in 2022 and headquartered in Newark, Delaware, Covation Biomaterials LLC is a global innovator of commercially available, high-performance, sustainable solutions for the apparel and home goods industries.
The company’s inherits legacy of scientific innovation began with the commercialization of the Sorona® polymer 25 years ago and continues today with a commitment to delivering novel biomaterials at scale across multiple industries.
